LOVE TED W 1188919 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-06-02 | 2023-05-31 | 2023-05-31 | 4 | Love Ted W | DIRECTOR | acq | 2044.0 | 30.29 | 0.11 | 0.0 | Direct | Common Stock | SEAGEN INC. | code A | 6748.0 | 187.5 (SGEN) |
2023-06-26 | 2023-06-23 | 2023-06-23 | 4 | Love Ted W | DIRECTOR | acq | 7747.0 | 20.97 | 0.17 | 0.0 | Direct | Class A Ordinary Shares | ROYALTY PHARMA PLC | code A | 36941.0 | 448.2 (RPRX) |
2023-12-15 | 2023-12-14 | 2023-12-14 | 4 | Love Ted W | DIRECTOR | dsp | 4255.0 | 100.0 | 0.23 | 229.0 | Direct | Common Stock | SEAGEN INC. | code D | 0.0 | 188.66 (SGEN) |
2024-02-06 | 2024-02-02 | 2024-02-02 | 4 | Love Ted W | DIRECTOR | acq | 512.0 | 100.0 | 0.0 | 0.0 | Direct | Common Stock | GILEAD SCIENCES, INC. | code A | 512.0 | 1246.04 (GILD) |
2024-05-09 | 2024-05-08 | 2024-05-08 | 4 | Love Ted W | DIRECTOR | acq | 2310.0 | 81.86 | 0.02 | 0.0 | Direct | Common Stock | GILEAD SCIENCES, INC. | code A | 2822.0 | 1245.85 (GILD) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-08-04 | 2023-08-03 | 2023-08-03 | 4 | Love Ted W | DIRECTOR | acq | 75000.0 | 100.0 | 6.53 | 10.57 | Direct | Stock Option (Right To Buy) | STRUCTURE THERAPEUTICS INC. | code A | 75000.0 | 114.8 (GPCR) |
2023-12-15 | 2023-12-14 | 2023-12-14 | 4 | Love Ted W | DIRECTOR | dsp | 11598.0 | 100.0 | 0.61 | 149.24 | Direct | Stock Options (Right To Buy) | SEAGEN INC. | code D | 0.0 | 188.66 (SGEN) |
2023-12-15 | 2023-12-14 | 2023-12-14 | 4 | Love Ted W | DIRECTOR | dsp | 2493.0 | 100.0 | 0.13 | 0.0 | Direct | Restricted Stock Units | SEAGEN INC. | code D | 0.0 | 188.66 (SGEN) |
2024-02-06 | 2024-02-02 | 2024-02-02 | 4 | Love Ted W | DIRECTOR | acq | 2996.0 | 100.0 | 0.02 | 76.96 | Direct | Non Qualified Stock Option (Right To Buy) | GILEAD SCIENCES, INC. | code A | 2996.0 | 1246.04 (GILD) |
2024-05-09 | 2024-05-08 | 2024-05-08 | 4 | Love Ted W | DIRECTOR | acq | 12648.0 | 100.0 | 0.1 | 64.92 | Direct | Non Qualified Stock Option (Right To Buy) | GILEAD SCIENCES, INC. | code A | 12648.0 | 1245.85 (GILD) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)